Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Voraxaze (glucarpidase)
DRUG
2 trials
Sponsors
M.D. Anderson Cancer Center
, BTG International Inc.
Conditions
Hematologic Malignancy
Neoplasms
Solid Tumor
Phase 1
Voraxaze for Delayed Methotrexate Clearance
Terminated
NCT00424645
M.D. Anderson Cancer Center
Hematologic Malignancy, Solid Tumor
Start: 2007-01-31
End: 2008-01-31
Updated: 2012-12-06
Unknown Phase
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
NCT00481559
BTG International Inc.
Neoplasms
Updated: 2014-01-17
Related Papers
Immunogenicity and safety of glucarpidase for methotrexate toxicity.
Journal of Clinical Oncology
2014-05-20
4 citations